Pregnancy News and Research

Latest Pregnancy News and Research

Antimalarial drugs administered during pregnancy safer than contracting malaria, study suggests

"Antimalarial drugs are safer for pregnant women than contracting the disease," according to a study from the University of Oxford published in the journal Lancet Infectious Diseases on Tuesday that "assessed the effects of malaria and its treatment in the first trimester of pregnancy," HealthCanal.com reports.

16 Dec 2011

Vaginal progesterone safe and effective in preventing preterm birth

Women with a short cervix should be treated with vaginal progesterone to prevent preterm birth, according to a landmark study by leading obstetricians around the world. Vaginal progesterone decreased the rate of preterm birth by 42%, and significantly reduced the rate of respiratory distress syndrome and the need for mechanical ventilation, as well as a composite of several complications of premature newborns.

15 Dec 2011

Vaginal progesterone reduces rate of preterm birth and neonatal complications

A team of investigators of the National Institutes of Health housed at the Detroit Medical Center (DMC) and Wayne State University (WSU) published today that performing a cervical ultrasound in all pregnant women and treating those with a short cervix with vaginal progesterone reduces the rate of preterm birth and neonatal complications.

15 Dec 2011

Experts warn expectant moms about dangers of common cold medicines during pregnancy

Experts in pregnancy and breastfeeding health at the California Teratogen Information Service (CTIS) Pregnancy Health Information Line warn expectant moms about the potential dangers of common cold medicines during pregnancy.

15 Dec 2011

Half of all stillbirths result from pregnancy disorders, placental conditions

Half of all stillbirths result from pregnancy disorders and conditions affecting the placenta, according to results reported by a National Institutes of Health research network established to find the causes of stillbirth as well as ways to prevent or reduce its occurrence.

15 Dec 2011

$Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL$

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Celgene International Sàrl, a subsidiary of Celgene Corporation, (NASDAQ: CELG), announced final results from a phase II investigational study evaluating the combination of REVLIMID® (lenalidomide) and rituximab in 59 patients with relapsed or refractory chronic lymphocytic leukemia (CLL). These data were presented at the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.

14 Dec 2011

Mothers of very low birth-weight infants suffer worse health

Babies born at very low birth weights struggle in their early years and a new study by University of Wisconsin-Madison researchers suggests that their mothers do, too.

14 Dec 2011

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.

14 Dec 2011

With federal court action looming, Sebelius says Plan B decision 'not about politics'

A federal judge in Brooklyn will hear arguments Tuesday afternoon on the constitutionality of the federal decision regarding the access teenage girls should have to morning-after contraceptive pills. Meanwhile, Health and Human Services Secretary Kathleen Sebelius said the decision about Plan B's over-the-counter status was not a political one.

14 Dec 2011

Viewpoints: The high cost of treating patients who may die; Young girls and Plan B

You've probably heard that we spend a lot of money on patients who die. It's true. ... But what about my patient? How could it be that we were prudent with health care dollars because he lived, but would have been described as wasteful had he died? Doctors in an emergency room cannot know which will occur. They do not have divining rods that direct them to patients they can save and away from those they can't. Rather, caring for the sick means caring for people who may die.

14 Dec 2011

Stillbirth linked with factors identifiable before or at the start of pregnancy

Stillbirth is associated with a range of health and socio-demographic factors identifiable before or at the start of pregnancy, including prior pregnancy outcomes, ethnicity and modifiable health factors, such as diabetes, obesity and smoking.

14 Dec 2011

Link between maternal pre-pregnant BMI, weight change in pregnancy and offspring birthweight

A new study published in the journal Acta Obstetricia et Gynecologica Scandinavica (AOGS) reveals that both pre-pregnant weight (body mass index, BMI) and weight gain in pregnancy are important predictors of babies' birthweight. This is important since high birthweight may also predict adult overweight.

14 Dec 2011

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.

14 Dec 2011

Incyte announces further analyses from Jakafi Phase III trial on myelofibrosis

Incyte Corporation today announced that further analyses from the global, pivotal Phase III clinical program of Jakafi (ruxolitinib or INC424) are being presented at the 2011 American Society of Hematology (ASH) Annual Meeting.

13 Dec 2011

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.

13 Dec 2011

Infants with low salivary cortisol levels develop fewer allergies

A new study from the Swedish medical university Karolinska Institutet shows that infants with low concentrations of the stress-related hormone cortisol in their saliva develop fewer allergies than other infants. Hopefully this new knowledge will be useful in future allergy prevention.

13 Dec 2011

Viewpoints: Blocking an abortion option for military women; Plan B pushback; Solving Wis. doc shortage

Republican Senate leaders have an odd way of showing gratitude for the dedication and sacrifices of the more than 200,000 women on active duty in the military. Late last month, they blocked consideration of an amendment to the National Defense Authorization Act that would have lifted the statutory ban that denies female service members coverage for abortion care in cases of rape and incest.

13 Dec 2011

Abortion does not raise risk of mental ailment: Experts

A major review by experts concludes that abortion does not raise the risk of a woman suffering mental health problems. Data from 44 studies showed women with an unwanted pregnancy have a higher incidence of mental health problems in general. This is not affected by whether or not they have an abortion or give birth.

12 Dec 2011

Celgene announces interim results of REVLIMID study on CLL

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced interim results of CLL-009, a study evaluating three starting doses of REVLIMID (lenalidomide), followed by step-wise dose escalation as tolerated in patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

12 Dec 2011

Incidence of TB diagnosis is increased in mothers postpartum

The incidence of tuberculosis (TB) diagnosis is significantly increased in mothers postpartum, suggesting a potential new population to target for screening, according to a new UK-wide cohort study.

12 Dec 2011

Pregnancy News and Research

Latest Pregnancy News and Research

Antimalarial drugs administered during pregnancy safer than contracting malaria, study suggests

Vaginal progesterone safe and effective in preventing preterm birth

Vaginal progesterone reduces rate of preterm birth and neonatal complications

Experts warn expectant moms about dangers of common cold medicines during pregnancy

Half of all stillbirths result from pregnancy disorders, placental conditions

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Mothers of very low birth-weight infants suffer worse health

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

With federal court action looming, Sebelius says Plan B decision 'not about politics'

Viewpoints: The high cost of treating patients who may die; Young girls and Plan B

Stillbirth linked with factors identifiable before or at the start of pregnancy

Link between maternal pre-pregnant BMI, weight change in pregnancy and offspring birthweight

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

Incyte announces further analyses from Jakafi Phase III trial on myelofibrosis

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Infants with low salivary cortisol levels develop fewer allergies

Viewpoints: Blocking an abortion option for military women; Plan B pushback; Solving Wis. doc shortage

Abortion does not raise risk of mental ailment: Experts

Celgene announces interim results of REVLIMID study on CLL

Incidence of TB diagnosis is increased in mothers postpartum

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in